New Delhi: The Bharat Biotech-manufactured Covaxin is overall 77.8 per cent effective against COVID-19, the vaccine-maker said via a statement citing third phase data of clinical trials. The data though is not peer-reviewed.
The vaccine provides “65.2 per cent protection” against the new Delta variant, which is said to be highly infectious, the statement said.
“We are proud to put India on the global map with scientific conviction, competence and commitment. Covaxin scores 10 world-class publications endorsing Innovation, clinical research, data, safety, efficacy. Thank collaborators & Positive BB teamwork enduring a pandemic (sic),” Bharat Biotech co-founder Suchitra Ella said through a late-night tweet.
Bharat Biotech further said in a statement, “Efficacy analysis demonstrates Covaxin to be 77.8 per cent effective against symptomatic COVID-19, through evaluation of 130 confirmed cases, with 24 observed in the vaccine group versus 106 in the placebo group.”
ALSO READ: Covaxin Effective For Delta Variant, Says Top US Health Institute
Jeypore: Odisha Chief Minister Naveen Patnaik’s close aide and senior leader V K Pandian on…
Balasore: A farmer was killed and a minor girl critically injured in separate incidents of…
New Delhi: Google suffered a widespread outage around the world on Wednesday as users in…
Ranchi: Jharkhand Congress’ official X account was on Wednesday withheld by the microblogging site in…
Bhubaneswar: Two Bhubaneswar-bound flights were diverted to Kolkata on Wednesday as landing was not possible…
New Delhi: Following Supreme Court’s order, the Election Commission of India (ECI) has been forced…
New Delhi: These are not good times for the once-mighty K Chandrashekar Rao, popularly known as…
Paradip: A minor boy went missing after he allegedly jumped into a at Paradip in…